AN Venture Partners I Overview

  • Fund Strategy
  • Venture

  • Fund Status
  • Closed

  • Size

  • Vintage
  • 2023

Vintage

  • Dry Powder

AN Venture Partners I General Information

Description

AN Venture Partners I is a venture capital fund managed by AN Venture Partners. The fund is located in Tokyo, Japan.

Contact Information

Fund Manager
Fund Manager Website
Fund Category
Venture Capital
Former Name
ANVenture Partners I
Open Date
Close Date
Fund Family
AN Venture Partners
Native Currency
USD
Fund Manager's Location
  • 7th Floor, Nihonbashi Muromachi Mitsui Tower
  • 3-2-1 Nihonbashi Muromachi, Chuo-ku
  • Tokyo, 103-0022
  • Japan
Fund Domiciles
Cayman Islands

AN Venture Partners I Investments (4)

AN Venture Partners I has made a total of 4 investments. Its most recent deal was a with Imbria Pharmaceuticals for . The deal was made on 16-Dec-2025.

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Imbria Pharmaceuticals 16-Dec-2025 Drug Discovery Clinical Trials - Phase 2
City Therapeutics 08-Oct-2024 Drug Discovery Startup
Typewriter Therapeutics 27-Feb-2024 Early Stage VC Discovery Tools (Healthcare) Stealth
Capacity Bio 31-Mar-2023 Early Stage VC Drug Discovery Pre-Clinical Trials
To view AN Venture Partners I’s complete investments history, request access »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AN Venture Partners I Investment Strategy

Investments by Industry

Investments by Deal Type

PitchBook helps you see a fund’s investments based on target industry, year and deal type—so you can quickly understand its strategy at a glance.

Request a free trial

AN Venture Partners I Limited Partners (5)

MUFG Bank is one of AN Venture Partners I’s 5 limited partners. Its latest Original was on 02-Jul-2025.

Limited Partner Name Type Status Commitment Date Commitment Type
MUFG Bank Current 02-Jul-2025 Original
Shionogi Current 02-Jul-2025 Original
Sumitomo Mitsui Banking Current 02-Jul-2025 Original
Otsuka Pharmaceutical Current 01-Jan-2024 Original
Japan Investment Corporation Current 04-Dec-2023 Original
To view AN Venture Partners I’s complete limited partners history, request access »

AN Venture Partners I Returns Data

The below charts are illustrative of the type of graphical data available to our clients and do not represent live data.

IRR (%)

 

DPI (x)

 

RVPI (x)

 

TVPI (x)

 

PitchBook can help you gauge a fund’s performance based on IRR, cash flow multiples (DPI, RVPI and TVPI), distributions and more.

Request a free trial

AN Venture Partners I FAQs

  • What is AN Venture Partners I?

    AN Venture Partners I is a venture capital fund managed by AN Venture Partners.

  • Who manages AN Venture Partners I?

    AN Venture Partners I is managed by AN Venture Partners.

  • Where is AN Venture Partners I domiciled?

    AN Venture Partners I is domiciled in Cayman Islands.

  • What is AN Venture Partners I's size?

    AN Venture Partners I has a size of .

  • What type of fund is AN Venture Partners I?

    The fund type of AN Venture Partners I is Venture.

  • What is the status of AN Venture Partners I?

    AN Venture Partners I is closed.

  • What has AN Venture Partners I invested in?

    AN Venture Partners I has made numerous investments in companies like Imbria Pharmaceuticals, City Therapeutics, and Typewriter Therapeutics within the Drug Discovery and Discovery Tools (Healthcare) industries.

  • What has AN Venture Partners I invested in recently?

    AN Venture Partners I's latest investment was on 16-Dec-2025 in Imbria Pharmaceuticals, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process